ERK1/2 Phosphorylation Predicts Survival Following Anti-Pd-1 Immunotherapy in Recurrent Glioblastoma
Víctor A. Arrieta,Andrew X. Chen,J. Robert Kane,Seong Jae Kang,Cynthia Kassab,Crismita Dmello,Junfei Zhao,Kirsten B. Burdett,Pavan S. Upadhyayula,Catalina Lee-Chang,Joseph Shilati,Dinesh Jaishankar,Li Chen,Andrew Gould,Daniel Zhang,Jinzhou Yuan,Wenting Zhao,Xiaoyang Ling,Jared K. Burks,Brice Laffleur,Christina Amidei,Jeffrey N. Bruce,Rimas V. Lukas,Jonathan T. Yamaguchi,David Cieremans,Gerson Rothschild,Uttiya Basu,Matthew McCord,Daniel J. Brat,Hui Zhang,Lee A. D. Cooper,Bin Zhang,Peter Sims,Tim F. Cloughesy,Robert Prins,Peter Canoll,Roger Stupp,Amy B. Heimberger,Craig Horbinski,Fabio M. Iwamoto,Raul Rabadan,Adam M. Sonabend WFNOS 2022 Abstract Book（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper